• Annals of Blood Cancer

    Annals of Blood Cancer

AIMS AND SCOPE

Annals of Blood Cancer

is an online, international, peer reviewed journal dedicated entirely to publish the scholarly articles on bone marrow, blood loss, leukemia, lymphoma, myeloma, immune system, and different kinds of blood cancers and their treatment procedures which enhances the preexisting knowledge in the related literature for betterment of human life. The journal primarily focus on providing a world-class open access publishing experience within the reach for all the professionals working in this area of research. The journal become itself an excellent source of scientific information and provide an open platform to read, share and distribute the latest research updates.
Blood cancers, or hematologic cancers is a broad subject that includes various types of neoplasms that includes Leukemia - Cancer that originates in blood-forming tissue, lymphoma: Cancer that develops in the lymphatic system, Hodgkin lymphoma - marked by the presence of an abnormal lymphocyte called the B lymphocyte, Multiple myeloma - Cancer that begins in the blood's plasma cells. All the blood cancers are diagnosed and treated with various sophisticated techniques that are advancing day-by-day. Continuous research is enabling emergence of new technologies that make the healthcare more effective and the updated research information is needed to be reached to all the clinical and medical professionals. Our journal plays a key role in disseminating the scientific knowledge within its scope.

About

Annals of Blood Cancer publish original research, review, case reports, clinical images, short communications, editorials, and letters related to Blood Cancer. The journal follows double blind peer review process and Open Access publishing. According to which, all articles published by Annals of Blood Cancer are made freely and easily accessible online upon publication without any barriers. The journal also focus on most important topics within the scope of the journal by publishing thematic issues or special issues.

  Bone marrow
  Blood loss
  Leukemia
  Lymphoma
  Myeloma
  Immune system
  Lymphoblastic
  Bruising
  Radiation Therapy
  Stem-cell transplant
  Acute promyelocyticleukaemia (APL)
  Hairy cell leukaemia (HCL)
  Large granular lymphocytic leukaemia (LGL)
  T-cell acute lymphoblastic leukaemia (T-ALL)
  Chronic myelomonocyticleukaemia (CMML)
Francisco J. Hernandez-Ilizaliturri

Francisco J. Hernandez-Ilizaliturri

Roswell Park Cancer Institute, USA

Deniz Peker

Deniz Peker

University of Alabama at Birmingham School of Medicine, USA

Dongsheng Xu

Dongsheng Xu

Hematopathology & Flow Cytometry Laboratory, USA

Mohamed Elemary

Mohamed Elemary

University of Saskatchewan, Canada

New submissions

The Document needs to be prepared in English language. The documents containing the manuscript should be a single Word or LaTeX file Any Figures or Tables related to the manuscript need to be attached along with the file. Documents containing the manuscript will be converted to PDF format.

Submit manuscript

Annals of Blood Cancer consider publishing of original research manuscripts, review manuscripts, case reports, clinical images, editorials, commentaries, opinion pieces, case studies, letters, and perspectives. For initial submission, we recommend authors to submit a single file (.doc) that contains the manuscript text, figures, tables and other supporting information. Submit manuscript as an email attachment to submission@remedypublications.com.

visit us

# 820 EL Camino Real, California, USA.94002

email us

info@remedypublications.com

call us

+1 415-690-1011